PLASMA SUBSTITUTE GELATIN
The shortage of blood sources, the prevalence of blood borne diseases, the development of autologous blood transfusion technology, the clarification of the clinical efficacy of plasma substitutes and the reduction of side effects have brought great opportunities to the market of plasma substitutes. The protein characteristics of gelatin determine that gelatin can be used as an important plasma expander. When the patient's condition is not serious, gelatin diluent can be used as a substitute for plasma.
The quality of substitute plasma gelatin products is closely related to the production technology level of enterprises. In recent years, with the rapid improvement of China's production technology, domestic enterprises producing substitute plasma gelatin have gradually increased. Therefore, the improvement of technology and quality of domestic plasma substitute gelatin products is conducive to the improvement of market sales of plasma substitute gelatin products.
The relevant policies issued by the state, especially the policies of pharmaceutical gelatin and plasma substitute industry and the promotion of industrial policies for the demand of downstream plasma substitute gelatin users, are directly related to the output and capacity of plasma substitute gelatin industry, and then affect the demand of the industry.
A survey report shows that with the continuous development of the global pharmaceutical industry and the increasing demand of patients for plasma substitute products, the growth of plasma substitute gelatin industry is driven. In the future, the market scale of plasma substitute gelatin industry has a large space for growth.
Post time: Sep-27-2021
